Selective RET Inhibitors (SRIs) in Cancer: A Journey from Multi-Kinase Inhibitors to the Next Generation of SRIs

RET is a receptor tyrosine kinase that plays an important role in the development of neurons and kidneys. The gene encoding the rearranged-during-transfection (<i>RET</i>) receptor tyrosine kinase was first discovered in the 1980s. Activating <i>RET</i> mutations and rearrang...

Full description

Bibliographic Details
Main Authors: Liz Clark, Geoff Fisher, Sue Brook, Sital Patel, Hendrik-Tobias Arkenau
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/16/1/31